NCT07083206View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

RecruitingOBSERVATIONAL
Enrollment

4,500

Participants

Timeline

Start Date

July 29, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

January 31, 2029

Conditions
HypercholesterolemiaDyslipidemias
Trial Locations (1)

Unknown

RECRUITING

Yongin Severance Hospital, Yongin-si

Sponsors
All Listed Sponsors
lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT07083206 - A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe | Biotech Hunter | Biotech Hunter